Clinical Edge Journal Scan

Antibiotics in Early Infancy Disrupt Gut Microbiome and Increase Risk for Atopic Dermatitis


 

Key clinical point: Antibiotic use early in life, especially within one year of age, disrupts the gut microbiome and increases the risk for atopic dermatitis (AD) at 5 years of age.

Major finding : Children who received antibiotics during the first year of life vs later were significantly more likely to develop AD at 5 years of age (adjusted odds ratio [aOR] 1.81; P < .001), with an increased number of antibiotic courses leading to a dose-response-like increased risk for AD (1 course: aOR 1.67; P = .0044; ≥ 2 courses: aOR 2.16; P = .0030).

Study details: This study analyzed the clinical data for AD diagnosis at age 5 years of 2484 children from the prospective, general population CHILD birth cohort, which enrolled pregnant women and infants with no congenital abnormalities born at ≥ 34 weeks of gestation.

Disclosures: The CHILD Study is funded by the Canadian Institutes of Health Research, the Allergy, Genes, and Environment Network of Centres of Excellence, Debbie and Don Morrison, and others. The authors declared no conflicts of interest.

Source: Hoskinson C, Medeleanu MV, Reyna ME, et al. Antibiotics within first year are linked to infant gut microbiome disruption and elevated atopic dermatitis risk. J Allergy Clin Immunol. 2024 (Apr 24). doi: 10.1016/j.jaci.2024.03.025 Source

Recommended Reading

Tralokinumab Normalizes Expression of Inflammatory Biomarkers in Atopic Dermatitis
MDedge Dermatology
No Improvement in Atopic Dermatitis Severity Upon Vitamin D Supplementation
MDedge Dermatology
Passive Smoking May Increase the Risk for Atopic Dermatitis in Offspring
MDedge Dermatology
Atopic Dermatitis Increases the Risk for Lymphoma
MDedge Dermatology
Real-World Study Confirms Efficacy of Baricitinib in Atopic Dermatitis
MDedge Dermatology
Filaggrin Loss-of-Function Variants Associated With Atopic Dermatitis Outcomes
MDedge Dermatology
Dupilumab Treatment for Atopic Dermatitis Increases Risk for Cutaneous T-Cell Lymphoma
MDedge Dermatology
Upadacitinib Improved Patient-Reported Outcomes in Atopic Dermatitis
MDedge Dermatology
ADHD Behavioral Patterns Linked to Prurigo Nodularis Development in Children With Atopic Dermatitis
MDedge Dermatology
Commentary: Studies Often Do Not Answer Clinical Questions in AD, May 2024
MDedge Dermatology